CCI imposes hefty penalties on ‘GSK’ and ‘Sanofi’ for collusive bidding in supply of vaccine for Haj

Competition Act: The Competition Commission of India has imposed a penalty of Rs. 60 Crores (approx.) on 'GlaxoSmithKline Pharmaceuticals' and a penalty of Rs. 3 Crores (approx.) on 'Sanofi' for collusive bidding in supply of a meningitis vaccine to the Government for Haj pilgrims. Both the parties have been directed to deposit the amount of penalty within 60 days of the receipt of order.